Unnamed: 0,title,date,stock,sentiment
1251883.0,"The Daily Biotech Pulse: Regulatory Delay For Novartis' Multiple Sclerosis Drug, FSD Gets Nod For COVID-19 Study",2020-06-03 07:39:00-04:00,TRIL,negative
1251884.0,Stocks That Hit 52-Week Highs On Tuesday,2020-06-02 10:33:00-04:00,TRIL,neutral
1251885.0,72 Biggest Movers From Friday,2020-06-01 04:53:00-04:00,TRIL,neutral
1251886.0,Why Trillium Therapeutics Is Trading Higher Today,2020-05-29 10:52:00-04:00,TRIL,neutral
1251887.0,Trillium Therapeutics shares are trading higher after the company provided an update on TTI-622 at ASCO. The company said dosing has progressed through first five cohorts up to 4 mg/kg dose level and showed a 'strong safety profile.',2020-05-29 10:16:00-04:00,TRIL,positive
1251888.0,"Trillium Therapeutics Provides Update On Phase I Dose Escalation Study Of CD47 Blocker TTI-622 At ASCO20; Dosing Has Progressed Through First Five Cohorts Up To 4 Mg/Kg Dose Level, Strong Safety Profile, With No Dose-limiting Toxicities Observed",2020-05-29 08:30:00-04:00,TRIL,positive
1251889.0,"The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant",2020-05-29 07:22:00-04:00,TRIL,positive
1251890.0,"JMP Securities Initiates Coverage On Trillium Therapeutics with Market Outperform Rating, Announces Price Target of $10",2020-05-26 09:01:00-04:00,TRIL,positive
1251891.0,The Week Ahead In Biotech: ASCO Presentations In The Spotlight,2020-05-24 14:40:00-04:00,TRIL,neutral
1251892.0,82 Biggest Movers From Yesterday,2020-05-19 04:44:00-04:00,TRIL,neutral
1251893.0,60 Biggest Movers From Yesterday,2020-05-15 04:53:00-04:00,TRIL,neutral
1251894.0,42 Stocks Moving In Thursday's Mid-Day Session,2020-05-14 12:55:00-04:00,TRIL,neutral
1251895.0,Shares of several healthcare companies are trading lower amid market weakness following US unemployment data and recent cautious comments from the WHO. Sentiment is also negative following cautious comments from Fed Chair Powell and bearish outlook from some major US investors on Wednesday. Negative investor sentiment has affected stocks across sectors for the session.,2020-05-14 11:18:00-04:00,TRIL,negative
1251896.0,20 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-05-14 07:40:00-04:00,TRIL,neutral
1251897.0,"Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C.  and Los Angeles County.",2020-05-13 12:49:00-04:00,TRIL,negative
1251898.0,Trillium Therapeutics Will Present Data on CD47 Blocker TTI-622 in Advanced Relapsed or Refractory Lymphoma at the ASCO20 Virtual Scientific Program May 29,2020-05-13 07:12:00-04:00,TRIL,positive
1251899.0,Shares of several healthcare companies are trading higher after US unemployment figures came in below consensus estimates. Equities have been strong this week amid a rebound in oil prices and some US states easing lockdown restrictions.,2020-05-08 10:56:00-04:00,TRIL,positive
1251900.0,19 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-05-06 07:36:00-04:00,TRIL,neutral
1251901.0,Trillium Therapeutics Reports $50M At-The-Market Offering,2020-05-06 07:08:00-04:00,TRIL,neutral
1251902.0,Trillium Therapeutics Filing Shows Registration For $50M Common Stock Shelf Offering,2020-05-05 17:22:00-04:00,TRIL,neutral
1251903.0,Trillium Therapeutics Inc Files For Mixed Shelf Of Up To $250M,2020-04-23 16:52:00-04:00,TRIL,neutral
1251904.0,70 Biggest Movers From Yesterday,2020-04-23 04:12:00-04:00,TRIL,neutral
1251905.0,Shares of several healthcare companies are trading higher as equities gain amid oil prices potentially stabilizing following the recent crash.,2020-04-22 12:03:00-04:00,TRIL,positive
1251906.0,17 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-04-22 07:38:00-04:00,TRIL,neutral
1251907.0,Shares of several healthcare companies are trading higher as markets gain on positive coronavirus outlook. Other potential positive sector catalysts include demand for therapies and medical supplies amid the coronavirus pandemic.,2020-04-14 10:59:00-04:00,TRIL,positive
1251908.0,"The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO",2020-04-08 07:53:00-04:00,TRIL,neutral
1251909.0,Shares of several healthcare companies are trading higher amid optimism that coronavirus cases in Asia are potentially easing. Global slowing cases could raise hopes of a sooner return to spending and economic activity. Several companies in the sector may also be benefiting from increased demand for therapies and medical supplies amid the coronavirus pandemic.,2020-04-07 07:48:00-04:00,TRIL,positive
1251910.0,10 Biotech Winners And Losers In Q1,2020-04-01 16:35:00-04:00,TRIL,negative
1251911.0,Shares of several companies in the healthcare space are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,2020-03-16 10:18:00-04:00,TRIL,negative
1251912.0,136 Biggest Movers From Yesterday,2020-03-13 05:20:00-04:00,TRIL,neutral
1251913.0,90 Stocks Moving In Thursday's Mid-Day Session,2020-03-12 12:21:00-04:00,TRIL,neutral
1251914.0,Shares of several healthcare companies are trading lower as equities sell off amid continued global coronavirus concerns. The virus has caused global economic disruption and negatively impacted stocks across sectors.,2020-03-12 09:26:00-04:00,TRIL,negative
1251915.0,RUMOR: Trillium Therapeutics Shares Spike to Session High As Hearing Dealreporter Speculation Co. Could Be Takeover Target,2020-03-11 09:36:00-04:00,TRIL,positive
1251916.0,Trillium Therapeutics Says Had ~$130M In Cash And Cash Equivalents As Of Feb. 28,2020-03-10 07:04:00-04:00,TRIL,neutral
1251917.0,52 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-03-09 08:04:00-04:00,TRIL,neutral
1251918.0,92 Biggest Movers From Yesterday,2020-03-05 04:41:00-05:00,TRIL,neutral
1251919.0,Shares of several healthcare-related companies are trading higher after Joe Biden secured several key wins in Super Tuesday. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.,2020-03-04 07:16:00-05:00,TRIL,positive
1251920.0,85 Biggest Movers From Yesterday,2020-03-04 05:04:00-05:00,TRIL,neutral
1251921.0,50 Stocks Moving In Tuesday's Mid-Day Session,2020-03-03 12:03:00-05:00,TRIL,neutral
1251922.0,Shares of several healthcare companies are trading lower in sympathy with the overall market. The Fed cut rates to combat the coronavirus outbreak which caused an initial spike but then continued to trade lower.,2020-03-03 11:55:00-05:00,TRIL,negative
1251923.0,"The Daily Biotech Pulse: GenMark Diagnostics Ships COVID-19 Test Kits, Karyopharm To Offer Shares, And More",2020-03-03 07:51:00-05:00,TRIL,positive
1251924.0,40 Stocks Moving in Tuesday's Pre-Market Session,2020-03-03 07:31:00-05:00,TRIL,neutral
1251925.0,108 Biggest Movers From Yesterday,2020-03-03 04:57:00-05:00,TRIL,neutral
1251926.0,55 Stocks Moving In Monday's Mid-Day Session,2020-03-02 11:52:00-05:00,TRIL,neutral
1251927.0,Trillium Therapeutics shares are trading higher. Traders attributing move to sympathy with Forty Seven after Gilead Sciences approached Forty Seven with a takeover offer.,2020-03-02 09:28:00-05:00,TRIL,positive
1251928.0,30 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-03-02 07:41:00-05:00,TRIL,neutral
1251929.0,30 Stocks Moving in Monday's Pre-Market Session,2020-03-02 07:21:00-05:00,TRIL,neutral
1251930.0,140 Biggest Movers From Friday,2020-03-02 04:43:00-05:00,TRIL,neutral
1251931.0,Trillium Therapeutics Responds To Market Activity; Says Wishes To Confirm It Is Not Aware Of Any Information Related To Co That Would Account For Recent Increase In Market Price,2020-02-28 12:33:00-05:00,TRIL,positive
1251932.0,"Trillium Therapeutics Shares Halted, News Pending",2020-02-28 12:26:00-05:00,TRIL,positive
1251933.0,86 Stocks Moving In Friday's Mid-Day Session,2020-02-28 12:19:00-05:00,TRIL,negative
1251934.0,Stocks That Hit 52-Week Highs On Friday,2020-02-28 10:11:00-05:00,TRIL,neutral
1251935.0,Mid-Morning Market Update: Markets Open Lower As Coronavirus Spreads; Foot Locker Posts Mixed Q4 Results,2020-02-28 10:09:00-05:00,TRIL,negative
1251936.0,Trillium Therapeutics shares are trading higher. Traders attributing move to sympathy with Forty Seven after Gilead Sciences approached Forty Seven with a takeover offer.,2020-02-28 09:23:00-05:00,TRIL,positive
1251937.0,50 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-02-28 08:34:00-05:00,TRIL,neutral
1251938.0,140 Biggest Movers From Yesterday,2020-02-28 05:00:00-05:00,TRIL,neutral
1251939.0,25 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-02-24 07:39:00-05:00,TRIL,neutral
1251940.0,95 Biggest Movers From Yesterday,2020-02-21 05:12:00-05:00,TRIL,neutral
1251941.0,30 Stocks Moving in Monday's Pre-Market Session,2020-02-10 07:30:00-05:00,TRIL,neutral
1251942.0,Stocks That Hit 52-Week Highs On Friday,2020-01-24 10:41:00-05:00,TRIL,neutral
1251943.0,"The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche's Cancer Drug Flunks Study",2020-01-24 07:43:00-05:00,TRIL,negative
1251944.0,52 Biggest Movers From Yesterday,2020-01-24 04:40:00-05:00,TRIL,neutral
1251945.0,146 Biotechnology Stocks Moving In Thursday's Session,2020-01-23 12:47:00-05:00,TRIL,neutral
1251946.0,Trillium Prices Offering Of 35.731M Common Shares And 1.25M Series II Non-Voting Convertible First Preferred Shares At $2.75/Unit,2020-01-23 08:17:00-05:00,TRIL,positive
1251947.0,15 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-01-23 07:36:00-05:00,TRIL,neutral
1251948.0,12 Biotechnology Stocks Moving In Thursday's Pre-Market Session,2020-01-23 07:35:00-05:00,TRIL,neutral
1251949.0,36 Stocks Moving in Thursday's Pre-Market Session,2020-01-23 07:16:00-05:00,TRIL,neutral
1251950.0,70 Biggest Movers From Yesterday,2020-01-23 05:52:00-05:00,TRIL,neutral
1251951.0,"12 Stocks To Watch For January 23, 2020",2020-01-23 04:59:00-05:00,TRIL,neutral
1251952.0,26 Biotechnology Stocks Moving In Wednesday's After-Market Session,2020-01-22 23:28:00-05:00,TRIL,neutral
1251953.0,36 Healthcare Stocks Moving In Wednesday's After-Market Session,2020-01-22 23:23:00-05:00,TRIL,neutral
1251954.0,Trillium shares are trading lower after the company reported a common stock offering of no disclosed size.,2020-01-22 16:03:00-05:00,TRIL,negative
1251955.0,"Trillium Reports Common Stock Offering, No Size Disclosed",2020-01-22 16:01:00-05:00,TRIL,negative
1251956.0,98 Biotechnology Stocks Moving In Wednesday's Session,2020-01-22 13:33:00-05:00,TRIL,neutral
1251957.0,116 Healthcare Stocks Moving In Wednesday's Session,2020-01-22 12:37:00-05:00,TRIL,neutral
1251958.0,46 Stocks Moving In Wednesday's Mid-Day Session,2020-01-22 12:05:00-05:00,TRIL,neutral
1251959.0,"Shares of nano-cap biotech company Trillium Therapeutics are trading higher on heightened volume, not currently seeing any company-specific news.",2020-01-22 10:24:00-05:00,TRIL,positive
1251960.0,20 Biotechnology Stocks Moving In Tuesday's After-Market Session,2020-01-21 23:35:00-05:00,TRIL,neutral
1251961.0,29 Healthcare Stocks Moving In Tuesday's After-Market Session,2020-01-21 23:28:00-05:00,TRIL,neutral
1251962.0,76 Biggest Movers From Yesterday,2020-01-17 04:54:00-05:00,TRIL,neutral
1251963.0,"Trillium Therapeutics Granted International Patent Titled 'Heteroaromatic-fused Imidazolyl Amides, Compositions And Uses Thereof As Sting Agonists'",2020-01-16 15:14:00-05:00,TRIL,positive
1251964.0,Trillium Therapeutics Reports Regained Compliance With Nasdaq Minimum Bid Price Requirement,2020-01-16 08:18:00-05:00,TRIL,neutral
1251965.0,75 Biggest Movers From Yesterday,2020-01-16 04:37:00-05:00,TRIL,neutral
1251966.0,Trillium Therapeutics shares are trading lower on a potential sell-off after the stock increased roughly 130% over the last 5 trading sessions.,2020-01-15 14:24:00-05:00,TRIL,positive
1251967.0,36 Stocks Moving In Wednesday's Mid-Day Session,2020-01-15 12:07:00-05:00,TRIL,neutral
1251968.0,41 Stocks Moving In Monday's Mid-Day Session,2020-01-13 12:21:00-05:00,TRIL,neutral
1251969.0,40 Stocks Moving In Friday's Mid-Day Session,2020-01-10 12:29:00-05:00,TRIL,neutral
1251970.0,Stocks That Hit 52-Week Highs On Friday,2020-01-10 12:18:00-05:00,TRIL,neutral
1251971.0,Trillium Therapeutics shares are trading higher. Not seeing any company-specific news to justify the price action.,2020-01-10 09:51:00-05:00,TRIL,positive
1251972.0,21 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-01-10 07:38:00-05:00,TRIL,neutral
1251973.0,33 Stocks Moving in Friday's Pre-Market Session,2020-01-10 07:26:00-05:00,TRIL,neutral
1251974.0,"The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx",2020-01-10 07:13:00-05:00,TRIL,positive
1251975.0,Stocks That Hit 52-Week Highs On Thursday,2020-01-09 15:15:00-05:00,TRIL,neutral
1251976.0,Trillium Therapeutics shares are trading higher. Not seeing any company-specific news to justify the price action.,2020-01-09 10:01:00-05:00,TRIL,positive
1251977.0,Shares of several cannabis companies are trading lower potentially in sympathy with Aurora Cannabis after the company announced it is selling one of its greenhouses. Analysts think this signifies cash issues. Investors may fear this could be an industry-wide problem and not just a problem specific to Aurora.,2020-01-08 11:44:00-05:00,TRIL,negative
1251978.0,Trillium Therapeutics shares are trading higher after the company provided an update on its TTI-621 and TTI-CD47 programs.,2020-01-07 08:56:00-05:00,TRIL,positive
1251979.0,Trillium Therapeutics shares are trading lower. Not seeing any news to justify the price action.,2020-01-06 09:59:00-05:00,TRIL,neutral
1251980.0,65 Biggest Movers From Yesterday,2020-01-03 04:36:00-05:00,TRIL,neutral
1251981.0,Mid-Afternoon Market Update: Signet Jewelers Falls Following Wells Fargo Downgrade; Trillium Therapeutics Shares Surge,2020-01-02 14:35:00-05:00,TRIL,positive
1251982.0,42 Stocks Moving In Thursday's Mid-Day Session,2020-01-02 12:13:00-05:00,TRIL,neutral
1251983.0,Mid-Day Market Update: Dow Rises 170 Points; Synthesis Energy Systems Shares Jump,2020-01-02 12:05:00-05:00,TRIL,positive
1251984.0,21 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-01-02 07:49:00-05:00,TRIL,neutral
1251985.0,Trillium Therapeutics shares are trading higher after Morgan Stanley on Tuesday reported a 5.9% passive stake in the company.,2020-01-02 07:26:00-05:00,TRIL,positive
1251986.0,Trillium Therapeutics Shares Rise 8.7% Premarket; Morgan Stanley Reported a 5.9% Passive Stake on Tuesday in a 13G Filing,2020-01-02 06:11:00-05:00,TRIL,positive
1251987.0,"Trillium Therapeutics Q3 Cash, Cash Equivalents, Marketable Securities Balance $36.2M vs $45.4M At Dec. 31, 2018",2019-11-14 07:16:00-05:00,TRIL,positive
1251988.0,"Trillium Therapeutics Shares Resume Trade, Up 9.7%",2019-10-22 09:54:00-04:00,TRIL,positive
1251989.0,"UPDATE: Trillium Therapeutics To Cut Staff By 40% From 43 To 26 Employees; Sees C$10M Reduction In Cash Outlay Per Qtr. In 1H'19, C$4-C$7M Per Qtr. In 2020",2019-10-22 09:07:00-04:00,TRIL,negative
1251990.0,"Trillium Shares Were Halted To Announce Corporate Restructuring, Will Resume Trade At 9:50 a.m. EDT",2019-10-22 09:06:00-04:00,TRIL,positive
1251991.0,"Trillium Therapeutics Reports Corporate Restructuring To Extend Co.'s Cash Runway, To Focus On Critical Value-Creating Activities",2019-10-22 09:04:00-04:00,TRIL,negative
1251992.0,Trillium Granted 180-Day Extension By NASDAQ To Regain Compliance With Minimum Bid Price Rule,2019-10-08 07:03:00-04:00,TRIL,positive
1251993.0,Trillium Therapeutics Appoints Jan Skvarka As President And Chief Executive Officer,2019-09-25 07:04:00-04:00,TRIL,neutral
1251994.0,H.C. Wainwright Downgrades Trillium Therapeutics to Neutral,2019-08-19 07:38:00-04:00,TRIL,neutral
1251995.0,Stocks That Hit 52-Week Lows On Thursday,2019-08-15 11:29:00-04:00,TRIL,negative
1251996.0,"The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings",2019-08-15 07:45:00-04:00,TRIL,neutral
1251997.0,Stocks That Hit 52-Week Lows On Wednesday,2019-08-14 12:46:00-04:00,TRIL,negative
1251998.0,"The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering",2019-08-14 07:50:00-04:00,TRIL,negative
1251999.0,Stocks That Hit 52-Week Lows On Tuesday,2019-08-13 11:08:00-04:00,TRIL,negative
1252000.0,"Trillium Therapeutics 1H EPS C$0.77 Down From C$1.57 YoY, Cales C$34M Up Form C$22.06M YoY",2019-08-13 07:12:00-04:00,TRIL,neutral
1252001.0,Trillium Offers Update: 'FDA meeting scheduled to discuss the pivotal path for intratumoral TTI-621 in CTCL',2019-07-24 07:15:00-04:00,TRIL,neutral
1252002.0,"The Daily Biotech Pulse: Decision Day For Regeneron-Sanofi, Vermillion Offering, PDL BioPharma CFO to Depart",2019-06-26 07:19:00-04:00,TRIL,neutral
1252003.0,"The Daily Biotech Pulse: Genfit NASH Drug In China, Conatus Explores Sale, Gilead Stitches Up Immuno-Oncology Partnership",2019-06-25 07:15:00-04:00,TRIL,neutral
1252004.0,Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico has renewed trade optimism and lifted economic outlook.,2019-06-04 13:07:00-04:00,TRIL,positive
1252005.0,"The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene & More, Edwards Recommends Rejection Of Mini-Tender Offer",2019-06-04 07:45:00-04:00,TRIL,negative
1252006.0,"The Daily Biotech Pulse: Breakthrough Therapy Designation For Iovance, Guardant Prices Offering, 2 Stocks to Debut",2019-05-23 07:37:00-04:00,TRIL,neutral
1252007.0,"The Daily Biotech Pulse: Tocagen Tumbles, OncoSec Offering, Novartis Asthma Combo Drug Study",2019-05-22 07:34:00-04:00,TRIL,neutral
1252008.0,Trillium Therapeutics Q1 EPS $(0.61) Beats $(0.91) Estimate,2019-05-13 07:20:00-04:00,TRIL,neutral
1252009.0,Trillium Therapeutics Announces Publication Highlighting Activity of TTI-621 in Sézary Syndrome Patients,2019-04-15 07:15:00-04:00,TRIL,neutral
1252010.0,Trillium Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency,2019-04-11 07:10:00-04:00,TRIL,neutral
1252011.0,Trillium Therapeutics Expands Immuno-Oncology Pipeline With STING Agonist Program,2019-04-02 07:12:00-04:00,TRIL,positive
1252012.0,"The Daily Biotech Pulse: Puma Biotech Earnings, Mersana Offering, Orphan Drug Designation For Ascendis",2019-03-01 08:50:00-05:00,TRIL,neutral
1252013.0,Trillium Prices 6.55M Share Common Stock Offering At $0.80/Share,2019-02-22 09:01:00-05:00,TRIL,positive
1252014.0,Trillium Therapeutics Shares Halted News Pending,2019-02-22 08:56:00-05:00,TRIL,positive
1252015.0,Trillium Reports Public Offering Of Units; Size Not Disclosed,2019-02-21 16:36:00-05:00,TRIL,neutral
1252016.0,"The Daily Biotech Pulse: Big Miss For Seattle Genetics; Hematology Conference Presentations; Gossamer Bio, Harpoon IPOs",2019-02-08 09:17:00-05:00,TRIL,negative
1252017.0,"The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen",2018-12-13 07:56:00-05:00,TRIL,positive
1252018.0,Trilogy Metals Reports Final Drill Results From Bornite Project,2018-12-13 06:35:00-05:00,TRIL,neutral
1252019.0,52 Biggest Movers From Yesterday,2018-12-13 04:54:00-05:00,TRIL,neutral
1252020.0,"Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 11, 2018",2018-12-12 11:47:00-05:00,TRIL,negative
1252021.0,"The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut",2018-12-07 08:04:00-05:00,TRIL,neutral
1252022.0,56 Biggest Movers From Yesterday,2018-12-04 05:02:00-05:00,TRIL,neutral
1252023.0,46 Stocks Moving In Monday's Mid-Day Session,2018-12-03 12:37:00-05:00,TRIL,neutral
1252024.0,"The Week Ahead In Biotech: ASH 2018, PDUFA Dates, Clinical Trials And Earnings",2018-11-25 09:41:00-05:00,TRIL,neutral
1252025.0,36 Stocks Moving In Tuesday's Mid-Day Session,2018-11-20 12:34:00-05:00,TRIL,neutral
1252026.0,"The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug, AbbVie-Neurocrine Report Positive Elagolix Results",2018-11-15 08:10:00-05:00,TRIL,positive
1252027.0,"The Daily Biotech Pulse: Mallinckrodt Faces FDA Panel, Reshape's Earnings, Vapotherm To Debut",2018-11-14 08:17:00-05:00,TRIL,neutral
1252028.0,"Trillium Therapeutics Reports Results For 9-Months Ended Sep. 30, 2018 EPS $2.49 vs $3.77 In Same Period Last Year",2018-11-14 07:08:00-05:00,TRIL,neutral
1252029.0,70 Biggest Movers From Yesterday,2018-11-13 04:46:00-05:00,TRIL,neutral
1252030.0,76 Biggest Movers From Yesterday,2018-11-02 06:12:00-04:00,TRIL,neutral
1252031.0,"Stocks Which Set New 52-Week Low Yesterday, October 31st",2018-11-01 10:37:00-04:00,TRIL,negative
1252032.0,"The Daily Biotech Pulse: AbbVie's Leukemia Drug Trial Meets Endpoint, Denali Strikes Collaboration Deal",2018-11-01 07:30:00-04:00,TRIL,negative
1252033.0,"The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price",2018-10-25 08:03:00-04:00,TRIL,negative
1252034.0,"The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares",2018-10-23 08:35:00-04:00,TRIL,positive
1252035.0,"Stocks Which Set New 52-Week Low Yesterday, October 9th",2018-10-10 11:01:00-04:00,TRIL,negative
1252036.0,"The Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer Shares",2018-10-10 07:56:00-04:00,TRIL,positive
1252037.0,"Stocks Which Set New 52-Week Low Friday, October 5th",2018-10-08 09:27:00-04:00,TRIL,negative
1252038.0,"The Daily Biotech Pulse: MediciNova Gets Orphan-Drug Status, KemPharm To Offer Shares, Emergent Buys Vaccine Maker",2018-10-05 08:35:00-04:00,TRIL,positive
1252039.0,45 Biggest Movers From Yesterday,2018-10-05 06:12:00-04:00,TRIL,neutral
1252040.0,32 Stocks Moving In Thursday's Mid-Day Session,2018-10-04 12:36:00-04:00,TRIL,neutral
1252041.0,Trillium Therapeutics Says Will Provide Update On TTI-621 Clinical Programs At 2 Scientific Conferences,2018-09-28 07:06:00-04:00,TRIL,neutral
1252042.0,Trillium Therapeutics Q2 EPS C$1.57,2018-08-08 07:27:00-04:00,TRIL,neutral
1252043.0,Trillium Therapeutics Reports Dosing Of First Patient In TTI-622 Phase 1 Trial,2018-06-14 07:04:00-04:00,TRIL,neutral
1252044.0,44 Biggest Movers From Yesterday,2018-06-12 04:49:00-04:00,TRIL,neutral
1252045.0,Trillium Therapeutics F-3 Shows Registration for 2.35M Share Offering By Selling Holders,2018-05-16 17:27:00-04:00,TRIL,positive
1252046.0,Trillium Therapeutics Q1 EPS $(0.65) vs $(1.46) In Prior Year Period,2018-05-11 07:02:00-04:00,TRIL,neutral
1252047.0,Trillium Therapeutics Gives Update on Its TTI-621 and TTI-622 Clinical Programs,2018-04-10 07:08:00-04:00,TRIL,neutral
1252048.0,26 Stocks Moving In Thursday's Pre-Market Session,2018-03-29 08:22:00-04:00,TRIL,neutral
1252049.0,Trillium Therapeutics Reports TTI-621 Received Orphan Drug Designation For Treatment Of Cutaneous T-Cell Lymphoma,2018-03-20 07:02:00-04:00,TRIL,neutral
1252050.0,Trillium Therapeutics Reports FY17 EPS $(4.61) vs $(4.06) Est.,2018-03-09 07:05:00-05:00,TRIL,neutral
1252051.0,40 Biggest Movers From Yesterday,2017-12-19 05:15:00-05:00,TRIL,neutral
1252052.0,40 Biggest Movers From Yesterday,2017-12-13 05:08:00-05:00,TRIL,neutral
1252053.0,30 Stocks Moving In Tuesday's Mid-Day Session,2017-12-12 12:33:00-05:00,TRIL,neutral
1252054.0,42 Biggest Movers From Yesterday,2017-12-12 05:56:00-05:00,TRIL,neutral
1252055.0,30 Stocks Moving In Monday's Mid-Day Session,2017-12-11 12:07:00-05:00,TRIL,neutral
1252056.0,"Trillium Reports 1.95M Share Common Stock, 400K Series II Non-Voting Convertible First Preferred Shares At $8.50/Share For Non-Brokered Private Placement Of $19.975M In Proceeds",2017-11-15 09:17:00-05:00,TRIL,positive
1252057.0,Trillium Therapeutics Shares Halted News Pending,2017-11-15 09:12:00-05:00,TRIL,positive
1252058.0,32 Biggest Movers From Yesterday,2017-10-18 03:53:00-04:00,TRIL,neutral
1252059.0,Trillium Therapeutics Reports 1H EPS $2.79 vs $1.90 In Same Period Last Year,2017-08-11 07:06:00-04:00,TRIL,neutral
1252060.0,18 Biggest Mid-Day Gainers For Monday,2017-07-17 12:30:00-04:00,TRIL,neutral
1252061.0,"Benzinga's Top Upgrades, Downgrades For July 17, 2017",2017-07-17 09:30:00-04:00,TRIL,positive
1252062.0,"H.C. Wainwright Initiates Coverage On Trillium Therapeutics Inc. - Common Shares with Buy Rating, Announces $7.00 Price Target",2017-07-17 07:06:00-04:00,TRIL,positive
1252063.0,Trillium Reports Expansion of Trial with TTI-621 to Include Combo with PD-1 Blockade,2017-06-07 07:03:00-04:00,TRIL,neutral
1252064.0,Trillium Shares to Resume Trade at 9 a.m. EDT,2017-05-26 08:59:00-04:00,TRIL,positive
1252065.0,Trilliuym Prices 2.75M Share Offering At $5/Share,2017-05-26 08:35:00-04:00,TRIL,positive
1252066.0,Trillium Shares Halted News Pending,2017-05-26 08:28:00-04:00,TRIL,positive
1252067.0,Trillium Therapeutics Announces Mixed Offering Common And Preferred Shares,2017-05-25 16:18:00-04:00,TRIL,positive
1252068.0,Trillium  Reports Q1 EPS $(1.46) vs $(0.92) Est.,2017-05-12 08:18:00-04:00,TRIL,neutral
1252069.0,"Trillium Therapeutics Gives Clinical Update On Phase 1 Trial Of TTI-621, Says Several Patients Showing Prelim Evidence Of Anti-Tumor Activity Of 33 Evaluable Patients",2017-04-03 07:08:00-04:00,TRIL,neutral
1252070.0,Trillium Therapeutics Says TTI--621's Half-Life and Receptor Occupancy Significantly Increased With Weekly Dosing,2017-02-24 11:36:00-05:00,TRIL,positive
1252071.0,Trillium Therapeutics Doses Initial Patient With TTI-621 in Phase 1 Solid Tumor Trial,2017-01-31 07:08:00-05:00,TRIL,negative
1252072.0,15 Biggest Mid-Day Gainers For Friday,2016-12-23 12:31:00-05:00,TRIL,neutral
1252073.0,Trillium Presents Initial Data From Ongoing Study of TTI-621 in Patients With Advanced Hematologic Malignancies at ASH 2016,2016-12-03 15:29:00-05:00,TRIL,positive
1252074.0,Mid-Afternoon Market Update: Crude Oil Down 2%; Metaldyne Performance Group Shares Spike Higher,2016-11-03 14:32:00-04:00,TRIL,negative
1252075.0,UPDATE: Cowen Believes Trillium's Study Advancement Into Expansion Arms Indications Co 'found a therapeutic window',2016-11-03 14:24:00-04:00,TRIL,neutral
1252076.0,"Cowen & Co Defending Trillium Therapeutics, Says Selloff Unwarranted Following Phase 1 Dose-Escalation Trail, Maintains Outperform",2016-11-03 14:23:00-04:00,TRIL,neutral
1252077.0,Trillium Shares Tick Higher Over Last Few Mins as Hearing Sell-Side Analyst Has Issued Mid-Day Defense Amid ~48% Downside in Price Today,2016-11-03 13:34:00-04:00,TRIL,positive
1252078.0,20 Biggest Mid-Day Losers For Thursday,2016-11-03 13:00:00-04:00,TRIL,negative
1252079.0,Trillium Therapeutics Inc. Shares Down ~47% After Safety Concerns With Lead Cancer Drug TTI-621 Were Earlier Disclosed In Abstract.,2016-11-03 11:13:00-04:00,TRIL,negative
1252080.0,Stocks Hitting 52-Week Highs,2016-10-07 10:20:00-04:00,TRIL,neutral
1252081.0,"Ladenburg Defending Trillium, Views TTI-621 Phase 1 Trial Initiaion As Positive, Reiterates Buy And $18 PT",2016-09-27 10:43:00-04:00,TRIL,positive
1252082.0,Benzinga's Volume Movers,2016-08-18 11:00:00-04:00,TRIL,neutral
1252083.0,Trillium Therapeutics Receives FDA Clearance to Proceed With TTI-621 in Clinical Trial Targeting Solid Tumors and Mycosis Fungoides,2016-08-17 07:02:00-04:00,TRIL,positive
1252084.0,Trillium Reports Q2 Cash Of $60.1M,2016-08-12 07:03:00-04:00,TRIL,neutral
1252085.0,Trilum Therapeutics Spikes to High of $10.41 on Volume,2016-08-03 13:02:00-04:00,TRIL,neutral
1252086.0,"Ladenburg Thalmann Analysts Initiate Coverage On Trillium At Buy, $18 Price Target",2016-08-03 11:51:00-04:00,TRIL,neutral
1252087.0,Benzinga's Top Initiations,2016-08-03 09:23:00-04:00,TRIL,positive
1252088.0,"Ladenburg Thalmann Initiates Coverage on Trillium Therapeutics at Buy, Announces $18.00 PT",2016-08-03 06:40:00-04:00,TRIL,neutral
1252089.0,Trillium Reports Q1 Loss $7.2M,2016-05-13 07:08:00-04:00,TRIL,negative
1252090.0,Trillium Therapeutics to Privude Uopdate on SIRPaFc Immune Checkpoint Inhibitor Program Targeting CD47 Protein,2016-04-14 07:26:00-04:00,TRIL,positive
1252091.0,Trillium To Give Update On CD47 Program April 18th From 1pm-5pm CT,2016-04-14 07:08:00-04:00,TRIL,neutral
1252092.0,Trillium Reports $3.4M Gov't Co-Funded Translational Research Program,2016-03-10 09:05:00-05:00,TRIL,neutral
1252093.0,"Trillium Acquires Fluroinov Pharma For $7M Cash Upfront And $25M In Additional Future Payments On Clinical, Regulatory Milestones",2016-01-27 08:15:00-05:00,TRIL,neutral
1252094.0,Trillium Therapeutics Provides Update on CD47 Program,2015-09-30 07:09:00-04:00,TRIL,neutral
1252095.0,Filing from Trillium Therapeutics Shows Registration for $100M Mixed Securities Shelf Offering,2015-05-29 14:05:00-04:00,TRIL,positive
1252096.0,Oppenheimer: Time To Buy Trillium Therapeutics,2015-05-15 10:35:00-04:00,TRIL,neutral
1252097.0,Oppenheimer Initiates Trillium Therapeutics With Outperform,2015-05-15 09:54:00-04:00,TRIL,neutral
1252098.0,Benzinga's Top Initiations,2015-05-15 09:47:00-04:00,TRIL,positive
1252099.0,"Oppenheimer Initiates Coverage on Trillium Therapeutics at Outperform, Announces $32.00 PT",2015-05-15 07:38:00-04:00,TRIL,neutral
1252100.0,Leerink Swann Initiates Trillium Therapeutics At Outperform,2015-04-27 09:18:00-04:00,TRIL,neutral
1252101.0,Benzinga's Top Initiations,2015-04-27 09:17:00-04:00,TRIL,positive
1252102.0,"Leerink Swann Initiates Coverage on Trillium Therapeutics at Outperform, Announces $29.00 PT",2015-04-27 06:52:00-04:00,TRIL,neutral
1252103.0,Benzinga's Volume Movers,2015-04-01 10:26:00-04:00,TRIL,neutral
1252104.0,Stocks Hitting 52-Week Highs,2015-04-01 10:13:00-04:00,TRIL,neutral
1252105.0,Trillium Therapeutics Prices ~1.522M Share Offering @$19.50/Share,2015-04-01 07:03:00-04:00,TRIL,positive
1252106.0,Trillium Therapeutics Announces $50M Stock Offering,2015-03-30 16:03:00-04:00,TRIL,neutral
1252107.0,Trillium Names Eric Sievers Chief Medical Officer,2015-03-27 07:02:00-04:00,TRIL,neutral
1252108.0,Benzinga's Volume Movers,2015-01-07 10:23:00-05:00,TRIL,neutral
1252109.0,Benzinga's Volume Movers,2015-01-06 10:45:00-05:00,TRIL,neutral
